ABBOTT LABS: Bid to Revoke Bayer’s Humera Patent Still Pending

Abbott Laboratories’ application to revoke Bayer HealthCare LLC’s Humira(R) patent remains pending.

In its 2009 annual report on Form 10-K, Abbott reported that litigation is pending in the Regional Court in…

ABBOTT LABS: Appeal to NYU, Centocor Patent Suit Ruling Pending

Abbott Laboratories’ appeal to the jury’s ruling on New York University and Centocor, Inc.’s patent infringement suit against the company remains pending.

In April 2007, NYU and Centocor filed a lawsuit…

ABBOTT LABS: Still Disputes Medinol Patent Claims in Europe

Abbott Laboratories continues to defend Medinol Limited’s patent infringement actions in The Netherlands and Germany.

In its 2009 annual report on Form 10-K filed with the Securities and Exchange Commission, Abbott…

FOREST LABORATORIES: No Trial Date Yet for Mylan Patent Suit

A new trial date has yet to be set for Forest Laboratories Inc.’s patent infringement complaint against Mylan.

In January 2008, Forest Laboratories and Merz, the Company’s licensor for Namenda, commenced…

FOREST LABS: Motion to Dismiss RxUSA Patent Suit on Appeal

Forest Laboratories Inc. and other defendants’ motions to dismiss

RxUSA Wholesale, Inc.’s patent infringement suit are pending on

appeal before the United States Court of Appeals for the Second

Circuit.

On July 14, 2006,…

FOREST LABS: To Appeal Jury Verdict on Infosint Patent Suit

Forest Laboratories Inc. plans to appeal a jury verdict on Infosint S.A.’s patent infringement suit to the U.S. Court of Appeals for the Federal Circuit.

In April 2006, an action was…

HOLOGIC INC: Conceptus Patent Suit Remains Pending in California

Conceptus, Inc.’s patent infringement suit against Hologic Inc. remains pending.

On May 22, 2009, Conceptus filed suit in the United States District Court for the Northern District of California seeking a…

HOLOGIC INC: Has Patent Settlement Agreement With Ethicon

Two lawsuits between Hologic, Inc., and Ethicon Endo-Surgery, Inc., alleging infringement of biopsy systems patents were settled on February 17, 2010.

On October 5, 2007, Ethicon, a Johnson & Johnson operating…

SHIRE LTD: INTUNIV Patent Suit Against Teva Remains Pending

Shire Ltd.’s patent infringement suit against Teva remains pending.

On March 16, April 5, and April 26, 2010, Shire received Paragraph IV Notice Letters from Teva, Actavis, and Anchen Pharmaceuticals Inc.,…

SHIRE LTD: Suit Against Nostrum Over CARBATROL ANDAs Settled

Shire Ltd.’s suit against Nostrum Pharmaceuticals, Inc., relating to their ANDAs seeking approval to market generic versions of 100mg, 200mg and 300mg strengths of CARBATROL was settled on March 10,…

Page 4 of 19« First...«23456»...Last »